Conversely, decreased TSP-1 may be associated with an increased risk of bladder cancer recurrence via the inhibitory effect of TSP-1 on VEGF-mediated tumour angiogenesis. The gene discussed is VEGFA; the disease is urinary bladder carcinoma.